Preclinical pharmacokinetic evaluation of a new formulation of a bifendate solid dispersion using a supercritical fluid chromatography-tandem mass spectrometry method

Mean plasma concentration profiles of the new formulation of bifendate solid dispersion after oral administration (n = 6).